ADENTRA (ADEN) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jul, 2026Executive summary
Q2 2024 featured significant developments, including a board change, a CAD 73M equity raise, and the CAD 130M acquisition of Woolf Distributing, expanding geographic reach and product range; Woolf is expected to be immediately accretive to adjusted EPS and EBITDA margin.
The company operates in a fragmented $43B North American market, serving 65,000+ customers with 175,000+ SKUs and $2.2B in 2023 sales, holding an estimated 6% share.
Strategic initiatives, including global sourcing, digital engagement (now 20% of transactions), and targeted M&A, underpin the Destination 2028 plan to reach $3.5B in annual sales.
Preliminary results from a U.S. trade case may lead to a refund of up to $25.7M in duties paid, with interest likely accruing.
Net income surged 81.6% to $17.0M, with basic EPS up 76.2% to $0.74 in Q2 2024.
Financial highlights
Q2 2024 sales were $549.5M, down 6.2% year-over-year due to product price deflation and a 1% volume decline.
Adjusted EBITDA rose 5.1% to $48.5M, and adjusted EPS increased 43.2% to $1.06 compared to Q2 2023.
Gross margin improved by 130 bps to 21.7%, marking the 13th consecutive quarter above 20%.
Operating expenses decreased 2.3% to $92.2M, reflecting tight cost control.
Operating cash flow before working capital changes rose to $37.5M, with 79% EBITDA conversion.
Outlook and guidance
Q3 adjusted EBITDA is expected to be similar to Q2, with Woolf's acquisition contributing for two months.
The company targets $3.5B in annual run-rate sales by 2028, driven by organic and acquisition-based growth.
End markets are expected to remain moderately impacted by inflation and high interest rates, but long-term fundamentals are strong.
Multi-year growth supported by under-built housing, demographic trends, and high home equity.
Destination 2028 plan targets $800M in run-rate acquired revenues by 2028.
Latest events from ADENTRA
- Q4 sales and margins improved, net income rose, but annual sales fell amid persistent headwinds.ADEN
Q4 20249 Jul 2026 - 2025 sales and net income grew with strong cash flow and higher dividends despite market headwinds.ADEN
Q4 20258 Jul 2026 - Sales up 1.8% to $568.8M, net income up 28.7%, and leverage ratio at 2.5x after Woolf acquisition.ADEN
Q3 20248 Jul 2026 - Q1 2026 delivered organic sales growth but faced margin and earnings pressure amid macro headwinds.ADEN
Q1 20267 May 2026 - Directors and auditors were elected with strong support; no shareholder questions were raised.ADEN
AGM 20265 May 2026 - Sales up 1.4% from acquisition, but organic sales and earnings declined amid macro headwinds.ADEN
Q1 202527 Apr 2026 - Q3 sales rose 4.1% to $592.1M, with margin gains and strong cash flow despite market headwinds.ADEN
Q3 202527 Apr 2026 - Sustained growth, strategic acquisitions, and operational excellence drive long-term value creation.ADEN
Investor presentation16 Mar 2026 - Strong growth, disciplined M&A, and operational excellence drive double-digit returns.ADEN
Investor presentation16 Mar 2026